The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
HIV Restriction Factors and Mechanisms of Evasion
Open accessAbstract
Retroviruses have long been a fertile model for discovering host-pathogen interactions and their associated biological principles and processes.These advances have not only informed fundamental concepts of viral replication and pathogenesis but have also provided novel insights into host cell biology.This is illustrated by the recent descriptions of host-encoded restriction factors that can serve as effective inhibitors of retroviral replication.Here, we review our understanding of the three restriction factors that have been widely shown to be potent inhibitors of HIV-1: namely, APOBEC3G, TRIM5a, and tetherin.In each case, we discuss how these unrelated proteins were identified, the mechanisms by which they inhibit replication, the means used by HIV-1 to evade their action, and their potential contributions to viral pathogenesis as well as inter-and intraspecies transmission.H IV-1, in common with all viruses, requires the concerted contributions of numerous positively acting cellular factors and pathways to achieve efficient replication (Bushman et al. 2009).Conversely, mammalian cells also express a number of diverse, dominantly acting proteins that are widely expressed and function in a cell-autonomous manner to suppress virus replication.These have been termed restriction factors and/or intrinsic resistance factors, and they provide an initial (or early) line of defense against infection as a component of, or even preceding, innate antiviral responses.This work discusses the most extensively described examples of such factors, focusing on their impact on HIV-1.These are the apolipoprotein
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Self-citationTetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
Self-citationThe cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Origins of HIV and the AIDS Pandemic
Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationVpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · cited 1×
“Indeed, two groups very recently reported using proteomic methods to identify SAMHD1 (sterile a motif domain-, HD domain-containing protein 1) as the myeloid-specific, degradable cellular target of HIV-2/SIVsm Vpx proteins (Hrecka et al. 2011; Laguette et al. 2011).”
BackgroundInduction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,050
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Self-citationHIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
Sawyer, S. L., Wu, L. I., Emerman, M., & Malik, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409853102 · Cited by 688
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
Sayah, D. M., Sokolskaja, E., Berthoux, L., & Luban, J. (2004) · Nature · doi:10.1038/nature02777 · Cited by 662
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., & Bieniasz, P. D. (2009) · Cell · doi:10.1016/j.cell.2009.08.039 · Cited by 595
Self-citationPositional cloning of the mouse retrovirus restriction gene Fvl
Best, S., Tissier, P. L., Towers, G., & Stoye, J. P. (1996) · Nature · doi:10.1038/382826a0 · Cited by 493
Inhibition of Retroviral RNA Production by ZAP, a CCCH-Type Zinc Finger Protein
Gao, G., Guo, X., & Goff, S. P. (2002) · Science · doi:10.1126/science.1074276 · Cited by 469
Trim5α protein restricts both HIV-1 and murine leukemia virus
Yap, M. W., Nisole, S., Lynch, C., & Stoye, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402876101 · Cited by 455
Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I., Cagney, G., Diamond, T. L., Zhou, H., Hazuda, D. J., Espeseth, A. S., König, R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000437 · Cited by 452
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., & Banting, G. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00129.x · Cited by 430
Sauter, D., Schindler, M., Specht, A., Landford, W. N., Münch, J., Kim, K.-A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B. F., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.10.004 · Cited by 429
Self-citationA Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction
Yap, M. W., Nisole, S., & Stoye, J. P. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.042 · Cited by 408
Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., & Evans, D. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000429 · Cited by 406
Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
Jouvenet, N., Neil, S. J. D., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., McNatt, M., Hatziioannou, T., & Bieniasz, P. D. (2009) · Journal of Virology · doi:10.1128/jvi.02211-08 · Cited by 380
Self-citationRetrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α
Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S., & Bieniasz, P. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402361101 · Cited by 373
Self-citationStremlau, M., Perron, M., Welikala, S., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3139-3145.2005 · Cited by 373
Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., & Harris, R. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq174 · Cited by 363
Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists
Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., Munch, J., Kirchhoff, F., Bieniasz, P. D., & Hatziioannou, T. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.008 · Cited by 355
Self-citationDouglas, J. L., Viswanathan, K., McCarroll, M. N., Gustin, J. K., Früh, K., & Moses, A. V. (2009) · Journal of Virology · doi:10.1128/jvi.00242-09 · Cited by 344
Keckesova, Z., Ylinen, L. M. J., & Towers, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402474101 · Cited by 344
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Koning, F. A., Newman, E. N. C., Kim, E.-Y., Kunstman, K. J., Wolinsky, S. M., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.01089-09 · Cited by 336
Self-citationTetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., & Bates, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811014106 · Cited by 335
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Bishop, K. N., Verma, M., Kim, E.-Y., Wolinsky, S. M., & Malim, M. H. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000231 · Cited by 328
Self-citationMitchell, R. S., Katsura, C., Skasko, M. A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E. B., Margottin-Goguet, F., Benarous, R., & Guatelli, J. C. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000450 · Cited by 326
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Iwatani, Y., Chan, D. S. B., Wang, F., Stewart-Maynard, K., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K., & Levin, J. G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm750 · Cited by 321
Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Kirchhoff, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.004 · Cited by 315
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
Self-citationAPOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 306
McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J. D., & Bieniasz, P. D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000300 · Cited by 298
Self-citationTRIM5α mediates the postentry block to N-tropic murine leukemia viruses in human cells
Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C., & Sodroski, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403364101 · Cited by 290
Evidence for a newly discovered cellular anti-HIV-1 phenotype
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M., & Malim, M. H. (1998) · Nature Medicine · doi:10.1038/3987 · Cited by 280
Self-citationAPOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 280
Self-citationLe Tortorec, A., & Neil, S. J. D. (2009) · Journal of Virology · doi:10.1128/jvi.01515-09 · Cited by 280
Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., & Malim, M. H. (2007) · Journal of Virology · doi:10.1128/jvi.02287-06 · Cited by 279
Self-citationNeil, S. J. D., Eastman, S. W., Jouvenet, N., & Bieniasz, P. D. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020039 · Cited by 276
Self-citationNeil, S. J. D., Sandrin, V., Sundquist, W. I., & Bieniasz, P. D. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.08.001 · Cited by 275
Self-citationCellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., & Bieniasz, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162299499 · Cited by 275
Self-citationWu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M., & Hope, T. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510483103 · Cited by 266
Species-Specific, Postentry Barriers to Primate Immunodeficiency Virus Infection
Hofmann, W., Schubert, D., LaBonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., & Sodroski, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10020-10028.1999 · Cited by 250
Hexagonal assembly of a restricting TRIM5α protein
Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I., & Yeager, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013426108 · Cited by 248
Mansouri, M., Viswanathan, K., Douglas, J. L., Hines, J., Gustin, J., Moses, A. V., & Früh, K. (2009) · Journal of Virology · doi:10.1128/jvi.00597-09 · Cited by 247
Madani, N., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10251-10255.1998 · Cited by 245
Cornejo, I., Andrini, O., Niemeyer, M. I., Marabolí, V., González-Nilo, F. D., Teulon, J., Sepúlveda, F. V., & Cid, L. P. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004402 · Cited by 245
Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity
Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S., & Bieniasz, P. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8969-8978.2005 · Cited by 245
Self-citationHigh-molecular-mass APOBEC3G complexes restrict Alu retrotransposition
Chiu, Y.-L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., & Greene, W. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604524103 · Cited by 244
Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins
LaRue, R. S., Andrésdóttir, V., Blanchard, Y., Conticello, S. G., Derse, D., Emerman, M., Greene, W. C., Jónsson, S. R., Landau, N. R., Löchelt, M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01976-08 · Cited by 228
Self-citationStructure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G
Chen, K.-M., Harjes, E., Gross, P. J., Fahmy, A., Lu, Y., Shindo, K., Harris, R. S., & Matsuo, H. (2008) · Nature · doi:10.1038/nature06638 · Cited by 221
Miyagi, E., Andrew, A. J., Kao, S., & Strebel, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813223106 · Cited by 221
Quantitative Membrane Proteomics Reveals New Cellular Targets of Viral Immune Modulators
Bartee, E., McCormack, A., & Früh, K. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020107 · Cited by 209
Independent evolution of an antiviral TRIMCyp in rhesus macaques
Wilson, S. J., Webb, B. L. J., Ylinen, L. M. J., Verschoor, E., Heeney, J. L., & Towers, G. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709003105 · Cited by 208
Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies
Wichroski, M. J., Robb, G. B., & Rana, T. M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020041 · Cited by 200
Song, B., Gold, B., O'hUigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6111-6121.2005 · Cited by 199
Small-molecule inhibition of HIV-1 Vif
Nathans, R., Cao, H., Sharova, N., Ali, A., Sharkey, M., Stranska, R., Stevenson, M., & Rana, T. M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1496 · Cited by 198
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species
Virgen, C. A., Kratovac, Z., Bieniasz, P. D., & Hatziioannou, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709258105 · Cited by 186
Self-citationInteractions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
Albin, J. S., & Harris, R. S. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001343 · Cited by 186
Kozak, S. L., Marin, M., Rose, K. M., Bystrom, C., & Kabat, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601901200 · Cited by 181
Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion
Gupta, R. K., Hué, S., Schaller, T., Verschoor, E., Pillay, D., & Towers, G. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000443 · Cited by 180
Evolution of a TRIM5-CypA Splice Isoform in Old World Monkeys
Newman, R. M., Hall, L., Kirmaier, A., Pozzi, L.-A., Pery, E., Farzan, M., O'Neil, S. P., & Johnson, W. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000003 · Cited by 179
APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis
Sadler, H. A., Stenglein, M. D., Harris, R. S., & Mansky, L. M. (2010) · Journal of Virology · doi:10.1128/jvi.00056-10 · Cited by 177
Wood, N., Bhattacharya, T., Keele, B. F., Giorgi, E., Liu, M., Gaschen, B., Daniels, M., Ferrari, G., Haynes, B. F., McMichael, A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000414 · Cited by 176
TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis
Brennan, G., Kozyrev, Y., & Hu, S.-L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709511105 · Cited by 171
RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F., & Malim, M. H. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000330 · Cited by 168
Self-citationViral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., & Spearman, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433165100 · Cited by 167
Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain
Hinz, A., Miguet, N., Natrajan, G., Usami, Y., Yamanaka, H., Renesto, P., Hartlieb, B., McCarthy, A. A., Simorre, J., Göttlinger, H. G., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.005 · Cited by 160
Gupta, R. K., Mlcochova, P., Pelchen-Matthews, A., Petit, S. J., Mattiuzzo, G., Pillay, D., Takeuchi, Y., Marsh, M., & Towers, G. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907075106 · Cited by 160
Diaz-Griffero, F., Qin, X.-R., Hayashi, F., Kigawa, T., Finzi, A., Sarnak, Z., Lienlaf, M., Yokoyama, S., & Sodroski, J. (2009) · Journal of Virology · doi:10.1128/jvi.01307-09 · Cited by 159
Hammonds, J. E., Wang, J.-J., Yi, H. L., & Spearman, P. W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000749 · Cited by 150
Goujon, C., Arfi, V., Pertel, T., Luban, J., Lienard, J., Rigal, D., Darlix, J., & Cimarelli, A. (2008) · Journal of Virology · doi:10.1128/jvi.01181-08 · Cited by 149
Goujon, C., & Malim, M. H. (2010) · Journal of Virology · doi:10.1128/jvi.00854-10 · Cited by 147
Self-citationCyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in Old World monkey cells
Berthoux, L., Sebastian, S., Sokolskaja, E., & Luban, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505659102 · Cited by 146
Li, X., & Sodroski, J. (2008) · Journal of Virology · doi:10.1128/jvi.01548-08 · Cited by 141
Liao, C., Kuang, Y., Liu, H., Zheng, Y., & Su, B. (2007) · AIDS · doi:10.1097/01.aids.0000304692.09143.1b · Cited by 140
Simon, J. H., Miller, D. L., Fouchier, R. A. M., Soares, M. A., Peden, K., & Malim, M. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1259 · Cited by 140
Self-citationLim, E. S., Malik, H. S., & Emerman, M. (2010) · Journal of Virology · doi:10.1128/jvi.00468-10 · Cited by 134
Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G
Cen, S., Peng, Z., Li, X., Li, Z., Ma, J., Wang, Y., Fan, B., You, X., Wang, Y., Liu, F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085308 · Cited by 121
Molecular evolution of the antiretroviral TRIM5 gene
Johnson, W. E., & Sawyer, S. L. (2009) · Immunogenetics · doi:10.1007/s00251-009-0358-y · Cited by 118
Kim, E., Tanmoy Bhattacharya, A., Kunstman, K., Swantek, P., Koning, F. A., Malim, M. H., & Wolinsky, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.01223-10 · Cited by 117
Self-citationRestriction factors: a defense against retroviral infection
Bieniasz, P. D. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00123-9 · Cited by 112
Self-citationKeckesova, Z., Ylinen, L. M. J., & Towers, G. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4683-4690.2006 · Cited by 112
Structural insight into the mechanisms of enveloped virus tethering by tetherin
Yang, H., Wang, J., Jia, X., McNatt, M. W., Zang, T. M., Pan, B., Meng, W., Wang, H., Bieniasz, P. D., & Xiong, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011485107 · Cited by 104
Self-citationSchubert, H., Zhai, Q., Sandrin, V., Eckert, D. M., Garcia‐Maya, M., Saul, L., Sundquist, W. I., Steiner, R. A., & Hill, C. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008206107 · Cited by 102
Active site remodeling switches HIV specificity of antiretroviral TRIMCyp
Price, A. J., Marzetta, F., Lammers, M., Ylinen, L. M. J., Schaller, T., Wilson, S. J., Towers, G. J., & James, L. C. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1667 · Cited by 101
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
Casartelli, N., Guivel‐Benhassine, F., Bouziat, R., Brandler, S., Schwartz, O., & Moris, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091933 · Cited by 92
Bergeron, J. R. C., Huthoff, H., Veselkov, D. A., Beavil, R. L., Simpson, P. J., Matthews, S., Malim, M. H., & Sanderson, M. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000925 · Cited by 91
Self-citationCyclophilin A: An auxiliary but not necessary cofactor for TRIM5α restriction of HIV-1
Stremlau, M. H., Song, B., Javanbakht, H., Perron, M. J., & Sodroski, J. (2006) · Virology · doi:10.1016/j.virol.2006.03.015 · Cited by 81
Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation
Bogerd, H. P., & Cullen, B. R. (2008) · RNA · doi:10.1261/rna.964708 · Cited by 75
Diaz‐Griffero, F., Kar, A. K., Perron, M. J., Xiang, S.-H., Javanbakht, H., Li, X., & Sodroski, J. (2007) · Journal of Virology · doi:10.1128/jvi.00703-07 · Cited by 73
Further Investigation of Simian Immunodeficiency Virus Vif Function in Human Cells
Gaddis, N., Sheehy, A. M., Ahmad, K. M., Swanson, C. M., Bishop, K. N., Beer, B., Marx, P. A., Gao, F., Bibollet‐Ruche, F., Hahn, B. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12041-12046.2004 · Cited by 70
Self-citationThe HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F
Hu, C., Saenz, D. T., Fadel, H. J., Walker, W., Peretz, M., & Poeschla, E. M. (2010) · Journal of Virology · doi:10.1128/jvi.00723-10 · Cited by 55
Stably Expressed APOBEC3F Has Negligible Antiviral Activity
Miyagi, E., Brown, C. R., Opi, S., Khan, M. H., Goila-Gaur, R., Kao, S., Walker, R. C., Hirsch, V. M., & Strebel, K. (2010) · Journal of Virology · doi:10.1128/jvi.01249-10 · Cited by 50
Langlois, M., & Neuberger, M. S. (2008) · Journal of Virology · doi:10.1128/jvi.02469-07 · Cited by 49
Nucleic acid metabolism and systemic autoimmunity revisited
Lee‐Kirsch, M. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27372 · Cited by 21
Cited by
Interferon-Stimulated Genes: What Do They All Do?
Schoggins, J. W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015756 · Cited by 1,036
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
The broad-spectrum antiviral functions of IFIT and IFITM proteins
Diamond, M. S., & Farzan, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3344 · Cited by 849
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hué, S., Barclay, W. S., Schulz, R., & Malim, M. H. (2013) · Nature · doi:10.1038/nature12542 · Cited by 583
Self-citation
Metadata
- Authors
- Malim, M. H., & Bieniasz, P. D.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-02-07
- Volume
- 2
- Issue
- 5
- Pages
- a006940-a006940
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2165070219
- Cited by
- 487
- References
- 109
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.